| Clinical and immunological effects of rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study M Vigna-Perez, B Hernández-Castro, O Paredes-Saharopulos, ... Arthritis research & therapy 8, 1-9, 2006 | 389 | 2006 |
| Regulatory T cells in patients with systemic lupus erythematosus B Alvarado-Sánchez, B Hernández-Castro, D Portales-Pérez, L Baranda, ... Journal of autoimmunity 27 (2), 110-118, 2006 | 363 | 2006 |
| Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells H De la Fuente, D Portales-Perez, L Baranda, F Diaz-Barriga, ... Clinical & Experimental Immunology 129 (1), 69-77, 2002 | 149 | 2002 |
| P2X7 and NRAMP1/SLC11 A1 gene polymorphisms in Mexican mestizo patients with pulmonary tuberculosis P Nino-Moreno, D Portales-Perez, B Hernandez-Castro, ... Clinical & Experimental Immunology 148 (3), 469-477, 2007 | 114 | 2007 |
| Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes NE Corral-Fernández, M Salgado-Bustamante, ME Martínez-Leija, ... Experimental and clinical endocrinology & diabetes, 347-353, 2013 | 109 | 2013 |
| In vitro assessment of agave fructans (Agave salmiana) as prebiotics and immune system activators L Moreno-Vilet, MH Garcia-Hernandez, RE Delgado-Portales, ... International journal of biological macromolecules 63, 181-187, 2014 | 100 | 2014 |
| Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis): the effect of clofazimine therapy L Baranda, B Torres-Alvarez, R Cortes-Franco, B Moncada, ... Archives of dermatology 133 (3), 325-329, 1997 | 92 | 1997 |
| Effect of arsenic on regulatory T cells B Hernandez-Castro, LM Doniz-Padilla, M Salgado-Bustamante, D Rocha, ... Journal of clinical immunology 29, 461-469, 2009 | 83 | 2009 |
| Pattern of expression of apoptosis and inflammatory genes in humans exposed to arsenic and/or fluoride M Salgado-Bustamante, MD Ortiz-Pérez, E Calderón-Aranda, ... Science of the total environment 408 (4), 760-767, 2010 | 74 | 2010 |
| Expression and function of the P2X7 purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis L Portales-Cervantes, P Niño-Moreno, L Doníz-Padilla, ... Human immunology 71 (8), 818-825, 2010 | 73 | 2010 |
| Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus D Portales-Perez, R Gonzalez-Amaro, C Abud-Mendoza, ... Lupus 6 (1), 48-56, 1997 | 63 | 1997 |
| IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus L Baranda, H De La Fuente, E Layseca-Espinosa, D Portales-Perez, ... Rheumatology 44 (12), 1507-1513, 2005 | 62 | 2005 |
| Placental exosomes isolated from urine of patients with gestational diabetes exhibit a differential profile expression of microRNAs across gestation HV Oostdam, A Sofía, JC Toro‑Ortíz, JA López, DE Noyola, ... International Journal of Molecular Medicine 46 (2), 546-560, 2020 | 58 | 2020 |
| Penetrating anti-DNA monoclonal antibodies induce activation of human peripheral blood mononuclear cells D Portales-Pérez, D Alarcón-Segovia, L Llorente, A Ruı́z-Argüelles, ... Journal of autoimmunity 11 (5), 563-571, 1998 | 56 | 1998 |
| The His155Tyr (489C> T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis L Portales-Cervantes, P Niño-Moreno, M Salgado-Bustamante, ... Cellular immunology 276 (1-2), 168-175, 2012 | 54 | 2012 |
| Pentoxifylline inhibits adhesion and activation of human T lymphocytes R González-Amaro, D Portales-Pérez, L Baranda, JM Redondo, ... The Journal of Immunology 161 (1), 65-72, 1998 | 54 | 1998 |
| Expression and function of P2X7 receptor and CD39/Entpd1 in patients with type 2 diabetes and their association with biochemical parameters MH García-Hernández, L Portales-Cervantes, N Cortez-Espinosa, ... Cellular immunology 269 (2), 135-143, 2011 | 50 | 2011 |
| Circulating miR‐146a, miR‐34a and miR‐375 in type 2 diabetes patients, pre‐diabetic and normal‐glycaemic individuals in relation to β‐cell function, insulin resistance and … RE García‐Jacobo, EE Uresti‐Rivera, DP Portales‐Pérez, ... Clinical and Experimental Pharmacology and Physiology 46 (12), 1092-1100, 2019 | 42 | 2019 |
| Increased levels of AIM2 and circulating mitochondrial DNA in type 2 diabetes Y Cataño Cañizalez, E Uresti Rivera, R Garcia Jacobo, D Portales Perez, ... Iranian Journal of Immunology 15 (2), 142-155, 2018 | 41 | 2018 |
| Clinical pharmacokinetics of rifampin in patients with tuberculosis and type 2 diabetes mellitus: association with biochemical and immunological parameters SE Medellín-Garibay, N Cortez-Espinosa, RC Milán-Segovia, ... Antimicrobial agents and chemotherapy 59 (12), 7707-7714, 2015 | 41 | 2015 |
